Watch Out For CEP Problems in 2011

Image via WikipediaThe European Directorate for the Quality of Medicines and Healthcare (EDQM) suspended or withdrew 19 certificates for active pharmaceutical ingredients in the latter half of 2010 because their manufacturers failed or refused inspections*. These are the main points:

1. Virtually all of the suppliers included in the list was from Asia.
2. The EDQM awards a CEP if the company declares GMP compliance (without a pre-approval inspection).
3. The EDQM conducts periodic inspections of API manufacturers, however, the EDQM has inspection capacity constraints and can only inspect about 30 sites a year.

This is important to follow, as you can expect the huge number of API suppliers to continue to come from that part of the world,

Acronyms:
-  Certificates of Suitability (CEPs)
-  Active pharmaceutical ingredient (API)

* SecuringPharma - EDQM suspends, withdraws 19 API certificates in 2H10

You might also be interested in:
Active Pharmaceutical Ingredients, Second Edition: Development, Manufacturing, and Regulation (Kindle edition)

Return Home: http://drughealth.blogspot.com/
GMP Posters
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/

Related articles

• Huber Receives Approval to Produce Active Pharmaceutical Ingredients (eon.businesswire.com)
• B. Braun Voluntarily Recalls Seven Lots of Heparin Manufactured in 2008 Due to Supplier-Initiated Recall of Heparin Active Pharmaceutical Ingredient (API) (fda.gov)